SynGen announces relocation of corporate headquarters

Oct 17 2014

SynGen, Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has moved its corporate headquarters to a new location in Sacramento, California. The headquarter’s new address is 100 Howe Avenue, Suite 185N, Sacramento, CA 95825-8219. All other contact information, including phone numbers, remains the same.

“As SynGen continues to grow, we need to expand our footprint,” said William Gerber, President and CEO of SynGen.

The new facility provides state-of-the-art laboratory and engineering areas, enabling us to better serve the needs of our customers and employees, and reflecting our long term commitment to quality.

About SynGen, Inc.

SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.

For more information about SynGen, visit the company’s website at www.syngeninc.com.